• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国斑秃成年患者的感知耻辱感

Perceived Stigma Among Adults With Alopecia Areata in the United States.

作者信息

Gauthier Genevieve, Hanson Kent A, Tran Helen, Napatalung Lynne, Bell Griffith, Sadrarhami Mojgan, Lee Lulu, Sternbach Nikoletta, Law Ernest H, Kurosky Samantha K

机构信息

Pfizer Inc, New York, New York, USA.

Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago, Chicago, Illinois, USA.

出版信息

J Dermatol. 2025 May 23;52(7):1185-91. doi: 10.1111/1346-8138.17786.

DOI:10.1111/1346-8138.17786
PMID:40407201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12231919/
Abstract

Alopecia areata (AA) can significantly impact mental/emotional quality of life, which may be partially attributed to disease-related stigma. We assessed patient-reported stigma in US adults with AA using data collected from the 2023 US National Health and Wellness Survey. Demographics, clinical characteristics, comorbidities, and perceived stigma were analyzed for patients with physician-diagnosed AA, stratified by self-reported disease severity. Data were weighted to match demographics of the US adult population. Of 75 007 (weighted n = 255.7 million) adults who completed the survey, 859 (weighted n = 2.9 million; 1.1%) self-reported physician-diagnosed AA. Among those reporting physician-diagnosed AA, 58.8%, 26.2%, and 15.0% self-reported mild, moderate, and severe AA, respectively. Overall, 40.1% reported experiencing symptoms of diagnosed emotional/mental health conditions in the past 12 months; 10.8% were receiving psychological counseling, and 10.8% were receiving medications for AA-related anxiety, depression, or sleep disorders. Internal or external stigma was reported by 79.2% of respondents. Adults with AA reported substantial emotional/mental health comorbidities, with few receiving counseling or therapeutic intervention. Dissatisfaction with their current hair growth was prevalent, and considerable stigma was reported across all levels of AA disease severity, highlighting the substantial impact of external perceptions of AA. Experiencing AA stigma may lead to social withdrawal and isolation, further exacerbating the psychosocial burden of AA.

摘要

斑秃(AA)会显著影响心理/情绪生活质量,这可能部分归因于与疾病相关的污名。我们使用从2023年美国国家健康与健康调查收集的数据,评估了美国成年斑秃患者报告的污名情况。对医生诊断为斑秃的患者的人口统计学、临床特征、合并症和感知到的污名进行了分析,并根据自我报告的疾病严重程度进行分层。对数据进行加权以匹配美国成年人口的人口统计学特征。在完成调查的75007名(加权n = 2.557亿)成年人中,859人(加权n = 290万;1.1%)自我报告医生诊断为斑秃。在报告医生诊断为斑秃的人群中,分别有58.8%、26.2%和15.0%的人自我报告为轻度、中度和重度斑秃。总体而言,40.1%的人报告在过去12个月中出现了已诊断的情绪/心理健康状况的症状;10.8%的人正在接受心理咨询,10.8%的人正在接受治疗斑秃相关焦虑、抑郁或睡眠障碍的药物治疗。79.2%的受访者报告有内部或外部污名。斑秃成年人报告有大量情绪/心理健康合并症,很少有人接受咨询或治疗干预。对当前头发生长不满意的情况很普遍,并且在斑秃疾病严重程度的各个层面都报告了相当程度的污名,这突出了外部对斑秃认知的重大影响。经历斑秃污名可能导致社交退缩和孤立,进一步加重斑秃的心理社会负担。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c607/12231919/00c7a93605df/JDE-52-1185-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c607/12231919/00c7a93605df/JDE-52-1185-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c607/12231919/00c7a93605df/JDE-52-1185-g001.jpg

相似文献

1
Perceived Stigma Among Adults With Alopecia Areata in the United States.美国斑秃成年患者的感知耻辱感
J Dermatol. 2025 May 23;52(7):1185-91. doi: 10.1111/1346-8138.17786.
2
Perceived Stigma and Mental Health Disorders Among Adults With Alopecia Areata Living in Japan.居住在日本的斑秃成年患者的感知耻辱感与心理健康障碍
J Dermatol. 2025 Aug;52(8):1255-1262. doi: 10.1111/1346-8138.17831. Epub 2025 Jun 27.
3
Understanding Eyebrow and Eyelash Involvement in Patients with Alopecia Areata and Responsiveness to Treatment with Baricitinib.斑秃患者眉毛和睫毛受累情况及巴瑞替尼治疗反应的研究
Br J Dermatol. 2025 Apr 3. doi: 10.1093/bjd/ljaf088.
4
Understanding Camouflaging, Stigma, and Mental Health for Autistic People in Japan.了解日本自闭症患者的伪装、污名化与心理健康。
Autism Adulthood. 2025 Feb 5;7(1):52-65. doi: 10.1089/aut.2023.0035. eCollection 2025 Feb.
5
Patient-Reported Psychosocial Burdens and Quality of Life and Work Productivity Impacts Among Patients with Clinically Distinct Alopecia Areata Severity Profiles.不同临床严重程度斑秃患者的患者报告心理社会负担、生活质量及工作效率影响
Adv Ther. 2025 Jul 21. doi: 10.1007/s12325-025-03302-8.
6
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
7
Feasibility and Acceptability of a Psychological Intervention for Internalized Health-Related Stigma Among Adults With Chronic Health Conditions: Preliminary Investigation.针对患有慢性健康状况的成年人内化的健康相关耻辱感的心理干预的可行性和可接受性:初步调查
JMIR Form Res. 2025 Jul 29;9:e69548. doi: 10.2196/69548.
8
Treatments for alopecia areata: a network meta-analysis.斑秃治疗方法的网状荟萃分析。
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD013719. doi: 10.1002/14651858.CD013719.pub2.
9
Investigation and analysis of mental health status of the older adult in western rural areas.西部农村地区老年人心理健康状况的调查与分析
Front Public Health. 2025 Jul 16;13:1612600. doi: 10.3389/fpubh.2025.1612600. eCollection 2025.
10
Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata.口服酪氨酸激酶3/肝细胞癌中表达的酪氨酸激酶家族激酶抑制剂芦可替尼24个月的疗效和安全性:斑秃的ALLEGRO IIb/III期和长期III期临床研究的综合分析
Br J Dermatol. 2025 Jan 24;192(2):215-227. doi: 10.1093/bjd/ljae365.

本文引用的文献

1
European expert consensus statement on the systemic treatment of alopecia areata.欧洲斑秃系统性治疗专家共识声明。
J Eur Acad Dermatol Venereol. 2024 Apr;38(4):687-694. doi: 10.1111/jdv.19768. Epub 2024 Jan 2.
2
National, State-Level, and County-Level Prevalence Estimates of Adults Aged ≥18 Years Self-Reporting a Lifetime Diagnosis of Depression - United States, 2020.全国、州级和县级≥18 岁成年人自报终身抑郁诊断患病率估计 - 美国,2020 年。
MMWR Morb Mortal Wkly Rep. 2023 Jun 16;72(24):644-650. doi: 10.15585/mmwr.mm7224a1.
3
An Updated Review on Current Treatment of Alopecia Areata and Newer Therapeutic Options.
斑秃当前治疗方法及新型治疗选择的最新综述
Int J Trichology. 2023 Jan-Feb;15(1):3-12. doi: 10.4103/ijt.ijt_28_21. Epub 2023 Apr 19.
4
The Invisible Impact of a Visible Disease: Psychosocial Impact of Alopecia Areata.一种显性疾病的隐形影响:斑秃的心理社会影响
Dermatol Ther (Heidelb). 2023 Jul;13(7):1503-1515. doi: 10.1007/s13555-023-00941-z. Epub 2023 Jun 8.
5
Prevalence and Odds of Depressive and Anxiety Disorders and Symptoms in Children and Adults With Alopecia Areata: A Systematic Review and Meta-analysis.斑秃患者中儿童和成人的抑郁和焦虑障碍及症状的患病率和优势比:系统评价和荟萃分析。
JAMA Dermatol. 2023 Mar 1;159(3):281-288. doi: 10.1001/jamadermatol.2022.6085.
6
Health-related quality of life in patients with alopecia areata: Results of a Japanese survey with norm-based comparisons.斑秃患者的健康相关生活质量:一项基于常模比较的日本调查结果
J Dermatol. 2022 Jun;49(6):584-593. doi: 10.1111/1346-8138.16364. Epub 2022 Mar 28.
7
Evaluation of Stigma Toward Individuals With Alopecia.脱发患者的污名化评估。
JAMA Dermatol. 2021 Apr 1;157(4):392-398. doi: 10.1001/jamadermatol.2020.5732.
8
Burden of Illness in Alopecia Areata: A Cross-Sectional Online Survey Study.斑秃患者的疾病负担:一项横断面在线调查研究。
J Investig Dermatol Symp Proc. 2020 Nov;20(1):S62-S68. doi: 10.1016/j.jisp.2020.05.007.
9
Stigmatization caused by hair loss - a systematic literature review.脱发导致的污名化——一项系统的文献综述。
J Dtsch Dermatol Ges. 2020 Dec;18(12):1357-1368. doi: 10.1111/ddg.14234. Epub 2020 Oct 4.
10
Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysis.斑秃、全秃和普秃的流行病学:系统回顾和荟萃分析。
J Am Acad Dermatol. 2020 Mar;82(3):675-682. doi: 10.1016/j.jaad.2019.08.032. Epub 2019 Aug 19.